Seven Top M&A Deal Killers In this whitepaper, our guest experts reveal how to avoid the seven top M&A deal killers. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Whitepapers
Capital Raising Landscape Infographic All investors are different. Start your capital raise with a sound grasp of the lay-of-the-land. Capital to raise Guides Infographics
Earnouts v2 Know when to use Earnouts to reduce risk, break a negotiation deadlock and get it done. Negotiation Whitepapers methodology
Capital Raising the Investor Landscape Start writing here...... Capital to raise Investment Whitepapers
Demystifying M&A Valuation Chinese 估值是每笔交易中最关键的部分,但它往往是最不被理解的部分。与Ascento Capital的管理合伙人本·博伊塞万(Ben Boissevain)一起探讨估值的细微差别、估值框架以及正确估值的流程。 Mergers & Acquisitions Valuation Whitepapers
Demystifying Tech M&A Valuation korean 가치 평가는 모든 거래에서 가장 중요한 부분이지만 중요한 만큼 이해가 어려운 분야입니다. 아센토 캐피털의 매니징 파트너인 벤 보이세빈 (Ben Boissevain)과 함께 "가치 평가"라는 단어의 의미, 개요 및 가치 평가를 성공적으로 처리하기 위한 과정을 알아보십시오. Technology Valuation Whitepapers
Calculating How Much Capital to Raise DELIVER A SLICK, FAST ONBOARDING PROCESS Capital to raise Feature Tour Fundraising Virtual Data Room Webinars
Capital Raising Term Sheet Get the strategies and insights to create a realistic term sheet that everyone can agree to. Fundraising Negotiation Webinars
Negotiating Working Capital Working capital can be difficult to understand and is one of the most conflicting issues in M&A negotiations and valuation. Mergers & Acquisitions Negotiation Webinars
New Innovations in Representations and Warranties Insurance to Accelerate Deals in 2021 In this webinar, Patrick Stroth of Rubicon M&A Insurance Services dives into the role representations and warranties insurance will play in your next M&A transaction. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Webinars
Due Diligence Checklist This all-purpose due diligence checklist contains a list of all the standard documents any buyer or partner might want to see. . BioPharma Due Diligence Due Diligence Checklists Energy Finance Fundraising Legal Life Sciences Mergers & Acquisitions Other Industries Other Topics Real Estate Top Content
Reverse Mergers and SPACs: Are APOs the New Norm for Biotechs Going Public? 2020 was an unprecedented year for Special Purpose Acquisition Corps (SPACs), an alternative public offering (APO) financing vehicle for listing on a public stock exchange. Best Practices & Trends Finance Life Sciences Mergers & Acquisitions Top Content Webinars